3D Medicines Inc.: Leading Hong Kong Biopharma’s Immuno‑Oncology Breakthroughs
3D Medicines Inc. pioneers immuno‑oncology drugs in China, offering new hope for cancer patients while attracting HKX investors with its innovative pipeline and market growth.
2 minutes to read